510 likes | 660 Views
April 18, 2012. Case Conference. Patient…. 16 year old Male presenting with right sided weakness. History of Present Illness. 7 days prior to admission. Gradual onset of right sided weakness (clumsy, could not write well) Complains of poor sensation over the right face.
E N D
April 18, 2012 Case Conference
Patient… • 16 year old Male presenting with right sided weakness
History of Present Illness 7 days prior to admission • Gradual onset of right sided weakness (clumsy, could not write well) • Complains of poor sensation over the right face. • Brought to an emergency room; Dx: Nerve impingement Reassurance • No relief of symptoms • Was transferred to another correctional facility • Symptoms got worse • Can’t walk straight • Loss some feeling over the right leg. Day of admission
Neurologic Examination 2+ 4/5 2+ 5/5 3+ 4/5 2+ 5/5
Differential Diagnosis • Neurologic • Ischemic vs Hemorrhagic Stroke • Peripheral nerve disease • Demyelinating Disease
And so the story goes… • Concerned about ischemic stroke • Labs were ordered • IVF started • MRI obtained
Laboratory Tests CBC Chemistries
Laboratory Tests CHEMISTRIES OTHER TESTS
Cerebrospinal Fluid Studies • CSF Cell count – normal • CSF Proteins – 23 • CSF Glucose – 79 • CSF Oligoclonal bands - Negative
Vincent Patrick Uy, MD PGY-1 The Child with A Demyelinating Disease
Introduction • No single diagnostic test is specific to particular diagnosis • Must rely on History and PE, clinical features and imaging to arrive at a plausible diagnosis • Uncommon in the pediatric age group • Think of RARE disorders!
The Working Diagnosis • Acute Disseminated Encephalomyelitis • Multiple Sclerosis • Optic Neuropathy • Transverse Myelitis • NeuromyelitisOptica
Leukodystrophies • Adrenoleukodystrophies • Cytoskeletal disorders (Alexander’s disease) • Myelin Basic Protein disorder • Organic acid diseases (Canavan disease) • Disorders of energy metabolism (MELAS) • Krabbe disease
Malignancies • CNS lymphomas • High-grade glioma • Large area of tumefactive demyelination • CSF studies show atypical cells
Collagen Vascular Diseases • Systemic Lupus Erythomatosus • Behcet’s disease • Neurosarcoidosis • Look for other symptoms • Anti-dsDNA, anti-phospholipids, elevated ACE enzymes
Optic Neuritis • May be a clinically isolated syndrome or part of another condition • Monocular in most adults; bilateral in most children 12-15 years old. • Symptoms can progress from several hours to days • Risk factor for developing frank Multiple Sclerosis
Optic Neuritis • Headache • Painful eye movements • Partial or complete vision loss • Relative afferent pupillary defect • Papillitis (75% in the acute phase)
Transverse Myelitis • Spinal cord disease without evidence of compression • Inflammation of the spinal cord • May present as a clinically isolated disorder or part of other conditions. • Most cases are idiopathic • Subset of patients develop TM after vaccination
Transverse Myelitis • Weakness, paresthesias, urinary and bladder problems • Hyperacute presentation • MRI shows contrast enhancing lesions on the cord
Transverse Myelitis • Idi0pathic Transverse Myelitis • Spontaneous but partial recovery in 1-3 months • 40% will have a persistent disability
NeuromyelitisOptica • Devic’s Disease • Combination of: • Optic neuritis • Transverse Myelitis • Seropositivity to NMO IgG antibodies • >3 contiguous spinal levels involved • Presentation can be primarily progressive with a fulminant course on presentation
Acute Disseminated Encephalomyelitis • Acute or subacute onset of multifocal neurologic deficits with encephalopathy • Often follows a viral infection or vaccination • Very uncommon illness • Autoimmune disorder of the CNS, triggered by environmental factors, in genetically susceptible individuals
Acute Disseminated Encephalomyelitis • Patients with ADEM, no matter what form, should have complete recovery to baseline.
Acute Disseminated Encephalomyelitis • Clinical Presentation • Febrile illness occurs in about 50-75% of children a month before neurologic symptoms appear. • Headache and meningeal signs • Encephalopathy (changes in mental status) • Acute hemiparesis, cerebellar ataxia, optic neuritis and spinal cord dysfunction are also common
Acute Disseminated Encephalomyelitis • Treatment • Fever, meningisimus, headaches, change in mental state, etc. Treat for suspected meningitis/encephalitis • Imaging may be obtained • High dose IV Glucocorticoids treatment for 3-5 days + steroid taper for 4-6 weeks • Methylprednisolone (10-30 mg/kg/d) • Dexamethasone (1 mg/kg/d)
Pediatric Multiple Sclerosis • Chronic disease characterized by repeated episodes of demyelination separated by space and time • Pediatric multiple sclerosis age of onset before 16 years old • 2.5/100,000 children
Pediatric Multiple Sclerosis • Genetic Susceptibility • Higher risk in monozygotic twins • Certain HLA subtypes are associated with increased risk • Environmental factors • Epstein-Barr Virus infection • Vitamin D deficiency
Pediatric Multiple Sclerosis • Diagnostic Criteria for Diagnosis of MS • Dissemination in Space • Dissemination in Time
Pediatric Multiple Sclerosis • Dissemination in Space • T2 lesions on MRI in at least two of the four MS-typical regions of the brain: • Periventricular • Juxtacortical • Infratentorial • Spinal Cord • Development of a further clinical attack implicating a different CNS site
Pediatric Multiple Sclerosis • Dissemination in Time • Simultaneous presence of asymptomatic gadolinium-enhancing and non enhancing lesions at anytime or a new T2 lesion on a follow-up MRI (irrespective of timing) • Development of a second clinical attack
Pediatric Multiple Sclerosis • Clinically Isolated Syndrome • INCREASED RISK for MS • Age 10 years or older • Optic nerve lesions • MRI pattern very typical for MS • DECREASED RISK for MS • Spinal cord lesions • Acute Mental status change (ADEM)
Pediatric Multiple Sclerosis • Treatment strategy (Acute setting) • IV pulse methylprednisolone 20-30 mg/kg/d x 5 days • Steroid taper 1 mg/kg/day for 4-6 weeks if without complete resolution • May re-treat with IV pulse methylprednisolone if symptoms recur during steroid taper
Pediatric Multiple Sclerosis • Treatment strategy (Chronic Therapy) • Glatiramer acetate • Interferons
Pediatric Multiple Sclerosis Monitoring patients after and ACUTE ATTACK Completion of steroid taper Neurologic exam at 1/3/6 months thereafter Clinically stable Symptomatic Send for MRI Annual Physical Examination
Patient Update… • Received 5 day high dose methylprednisolone therapy via IV • Completed steroid taper with prednisone PO • On follow-up 4/3/2012 Complete resolution of symptoms with return to baseline • Dismissed as a case of Acute Demyelination – Clinically Isolated Syndrome
Let’s demyelinate YOUR neurons! A 9 year old girl with anxiety disorder was diagnosed with acute demyelination because of sudden onset of left sided weakness and ataxia. Typical MS lesions which included the cerebellum and spinal cord were discovered after MRI. She comes to the clinic for the first time after completing 6 weeks of steroid taper. On further questioning, mom has missed several doses of her prednisone at home. So far, she never experienced symptoms again. Mom is concerned that the catastrophe might happen again. Which of the following conditions increases her risk to develop frank multiple sclerosis? • Non compliance to steroid taper • Her young age • Typical lesions were seen on MRI • Concomitant anxiety disorder • She doesn’t have risk factors that increase her risk to develop MS.
Now let’s give YOU ADEM! A 17 year old boy was brought to the ER for change in mental status. Ultimately, he was diagnosed with ADEM. He recovered after 5 days in the ICU and is now back to baseline. Which of the following environmental triggers could have increased his risk for developing the condition. • Receiving an unrecalled vaccine from the PMD a month ago during annual visit • Getting daily morning sun exposure for 15-20 minutes • Blurring of vision without eye pain • Experiencing an exudative sore throat which was negative on rapid strep test • Spider bite 2 weeks ago